Rathore S, Knowles P, Mann A P S, Dodds P A
The Cardiothoracic Centre, Thomas Drive, Liverpool L14 3PE, UK.
Eur J Intern Med. 2008 Nov;19(7):537-40. doi: 10.1016/j.ejim.2008.01.014. Epub 2008 Mar 14.
To determine whether patients presenting with chest pain who are at low to intermediate risk for ACS can safely be discharged from Accident and Emergency using Triple Cardiac Marker [TCM] [CK-MB, myoglobin, troponin I] without increasing risk and cost effective use of coronary care facilities.
Retrospective review of consecutive patients presented to A&E between Dec 2003 and July 2004 was performed and these patients were prospectively followed for six months for future coronary events and hospital admissions. A total of 325 patients presented to A&E with chest pain that were at low to intermediate risk for ACS. Paired TCM and ECGs were performed 2 h apart and the results were used to determine whether hospital admission was required. Follow up data was collected from hospital records, hospital database, GPS and patient interviews.
325 consecutive patients [225 men, 100 women; aged 18-97 years, median-68 years] were included in the study. Paired TCM was negative in 100 patients [30%] and they were discharged from A&E. The re-admission rate for this group of patients was 1% with ACS and no deaths from cardiac cause at six months. 36 [11%] had single TCM negative and were sent home with 3% re-admission rate with ACS and no death at six months. Subgroup analysis shows sensitivity and specificity of 85.7% and 96.5% respectively for TCM to diagnose ACS in this setting.
Almost one third of patients who presented with chest pain and low to intermediate probability of ACS were safely discharged from A&E following paired negative TCM. Six month re-admission rate with ACS in this group of patients was only 1% with no death. Therefore paired TCM can be used to safely discharge this group of patients. This marker has the potential to significantly reduce hospital admissions.
确定急性冠状动脉综合征(ACS)低至中度风险的胸痛患者使用三联心脏标志物[TCM][肌酸激酶同工酶(CK-MB)、肌红蛋白、肌钙蛋白I]能否在不增加风险的情况下安全地从急诊科出院,以及是否能有效利用冠心病监护设施。
对2003年12月至2004年7月期间连续就诊于急诊科的患者进行回顾性研究,并对这些患者进行为期六个月的前瞻性随访,以观察未来的冠状动脉事件和住院情况。共有325例因胸痛就诊于急诊科且为ACS低至中度风险的患者。每隔2小时进行一次配对的TCM和心电图检查,结果用于确定是否需要住院。随访数据从医院记录、医院数据库、全科医生记录和患者访谈中收集。
该研究纳入了325例连续患者[225例男性,100例女性;年龄18 - 97岁,中位数68岁]。100例患者(30%)的配对TCM结果为阴性,他们从急诊科出院。该组患者因ACS再次入院率为1%,六个月时无心脏原因导致的死亡。36例(11%)单次TCM结果为阴性并被送回家,因ACS再次入院率为3%,六个月时无死亡。亚组分析显示,在这种情况下TCM诊断ACS的敏感性和特异性分别为85.7%和96.5%。
几乎三分之一表现为胸痛且ACS可能性低至中度的患者,在配对TCM结果为阴性后从急诊科安全出院。该组患者因ACS六个月的再次入院率仅为1%,无死亡。因此,配对TCM可用于安全地让该组患者出院。该标志物有可能显著减少住院人数。